Global Erlotinib Hydrochloride Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
ReportPage
Report ID
687262
Published Date
05-Sep
No of Report Page
150
Report Category
Life Sciences
Editor's Rating
US $6,000.00
US $6,000.00
US $3,000.00

  • Report Details 
    Summary
    

    Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epiderm
    More...
  • Table Of Content 
    Table of Contents
    
Part 1 Market Overview
    
    1.1 Market Definition
    
    1.2 Market Development
    
        1.2.1 Current Situation
    
        1.2.2 Aspects of COVID-19 Impact
    
    1.3 By Type
    
                Table Type of Erlotinib Hydrochloride
    
                Figure Global Erlotinib Hydrochloride Market Share by Type in 2019
    
    1.4 By Application
    
                Table Application of Erlotinib Hydrochlor
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -